Entrepreneurs Invited to Apply for 2027 SPIE Startup Challenge
Entrepreneurs Invited to Apply for 2027 SPIE Startup Challenge
The competition will bring seven teams head-to-head in pursuit of $10,000 first prize
Entrepreneurs around the world are invited to apply for a chance to pitch their optics or photonics technologies or products to a panel of expert judges at the 17th annual SPIE Startup Challenge. SPIE, the international society of optics and photonics, holds the competition at Photonics West every January, with multiple teams walking away with cash prizes.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260811090450/en/

Coalesenz won first prize for their hand-held, point-of-care coagulation analyzer at the SPIE Startup Challenge at Photonics West in January 2026.
More than a simple pitch competition, the SPIE Startup Challenge is an entry point into the community of high-tech business development of new products in healthcare and deep tech, with an audience of experienced photonics innovators and investors. Cash prizes of $10,000, $5,000, and $2,500 are provided by Startup Challenge Founding Partner Jenoptik. Also given is the SPIE Jay Kumler Innovation Award, sponsored by Jenoptik, going to the finalist who best exemplifies former President of Jenoptik North America and SPIE Fellow, Jay Kumler’s, commitment to advancing optics and photonics innovation. Participating teams also receive mentoring by industry leaders and gain increased visibility from potential investors.
Previous first prize winners include Max-IR Labs, for facilitating carbon credits with precise CO2 monitoring in water systems, Advanced Optronics, which provides biocompatible integrated photonics for intraoperative monitoring in the cochlea, and Coalesenz, who also won the SPIE Jay Kumler Innovation Award for its hand-held coagulation analyzer.
“Winning first place at the SPIE Startup Challenge and becoming the inaugural recipient of the SPIE Jay Kumler Innovation Award was a defining moment for our team at Coalesenz. The recognition has sparked investor interest, supported new clinical collaborations, and helped us build momentum toward our vision of improving patients’ lives by transforming bleeding and coagulation management at the point of care. We are grateful to SPIE for providing an important platform that helps photonics startups turn innovation into real-world impact,” says Coalesenz Founder Seemantini Nadkarni.
New businesses and potential startups with optics or photonics technology can learn more about the 2027 Startup Challenge, including tips and training from leading experts, by visiting SPIE Startup Challenge. Applications close on 6 October 2026 with finalists being notified on 1 December 2026.
About SPIE
SPIE, the international society for optics and photonics, brings engineers, scientists, students, and business professionals together to advance light-based science and technology. The Society, founded in 1955, connects and engages with our global constituency through industry-leading conferences and exhibitions; publications of conference proceedings, books, and journals in the SPIE Digital Library; and career-building opportunities. Over the past five years, we have invested more than $26 million in the international optics community through our advocacy and support, including scholarships, educational resources, travel grants, endowed gifts, and public-policy development.
Lindsey McGuirk
Public Relations Manager
lindseym@spie.org
+1 360 685 5443
LI: @SPIE, the international society for optics and photonics
View source version on businesswire.com: https://www.businesswire.com/news/home/20260811090450/en/
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Dividend Stocks
12 Best Blue-Chip Stocks to Buy for the Long Term